AcelRx Pharmaceuticals
ACRX
$0.86
Share price
7.50%
Change (1 day)
40.98%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Total debt
Total debt on the balance sheet as of March 2023 : $3.36 M
According to AcelRx Pharmaceuticals 's latest financial reports the company's total debt is $3.36 M. A company’s total debt is the sum of all current and non-current debts.
AcelRx Pharmaceuticals - Total debt on balance sheet (from 2009 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $10.42 M | -44.03% |
| 2021-12-31 | $18.62 M | -27.26% |
| 2020-12-31 | $25.59 M | -13.97% |
| 2019-12-31 | $29.75 M | 148.16% |
| 2018-12-31 | $11.99 M | -37.21% |
| 2017-12-31 | $19.09 M | -11.38% |
| 2016-12-31 | $21.54 M | 3% |
| 2015-12-31 | $20.92 M | -15.99% |
| 2014-12-31 | $24.9 M | 73.38% |
| 2013-12-31 | $14.36 M | -10.07% |
| 2012-12-31 | $15.97 M | -16.28% |
| 2011-12-31 | $19.07 M | 58.87% |
| 2010-12-31 | $12 M | 23.37% |
| 2009-12-31 | $9.73 M | -21.08% |
| 2008-12-31 | $12.33 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | $6.08 M | 80.71% | 🇺🇸 USA |